WHO prequalifies new dengue vaccine
WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission intensity
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Takeda Pharma
Takeda becomes UNGC signatory in India
As a signatory, Takeda has committed to adopt the 10 principles of the UNGC
Takeda launches Adynovate to advance prophylaxis treatment for haemophilia patients in India
Adynovate, in combination with MYPKFIT, offers personalised treatment, and enables HCPs and patients to monitor factor levels from…
Takeda appoints Serina Fischer as General Manager for India
Fischer has over 17 years of experience in the biopharma industry, with expertise in strategy, sales, marketing and operations
Alembic Pharmaceuticals receives US FDA tentative approval for Vortioxetine tablets
The tablets are indicated for the treatment of Major Depressive Disorder (MDD)
US FDA approves Takeda’s Livtencity to treat people with post-transplant Cytomegalovirus infection
In the phase-III Solstice study, more than twice the proportion of adult transplant recipients with refractory or resistant (R/R)…
Takeda partners with JCR Pharmaceuticals to commercialise JR-141 protein
JR-141 is a potentially-transformative therapy designed to deliver proteins to the brain and peripheral tissues to treat…
Impact of COVID-19 and regulations for OTC segment
Many pharma companies are inclined to capture the OTC market in India due to the high consumer ratio, but COVID has shifted the…
Moderna might manufacture COVID-19 vaccines in Japan
The company is looking into making the vaccine in Asia, including in Japan Moderna Inc is considering manufacturing its…
Top 20 global pharma companies by MCap saw 10.2 per cent rise in MCap in Q2 2020: GlobalData
Johnson & Johnson maintained its top position with MCap growth of 7.2 per cent on a QoQ basis